Osteoarthritis of Hip
18
2
3
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
2 terminated out of 18 trials
81.8%
-4.7% vs benchmark
11%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (18)
A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
ArCom® and ArComXL® Polyethylene Data Collection
Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty
Investigation to Determine Safety of Taperloc Stems With BioGuard Coating When Used in Cementless Total Hip Arthroplasty
Mobile Technology to Support Physical Therapy Exercise
Femoral Lengthening Might Impair Physical Function and Lead to Structural Changes in Adjacent Joints
A Study of Posterior Hip Precautions After Total Hip Arthroplasty
Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement
The Viability of Short Stems in Total Hip Arthroplasty
Chlorzoxazone in Hip and Knee Arthroplasty
Continuous Lumbar Plexus Block With and Without Parasacral Block in Patients Undergoing Total Hip Replacement
Evaluation of the Wear of Vitamin E Treated Polyethylene Components in Primary THA Using RSA
Long-Term Multi-center Evaluation of E-Poly and Regenerex
Pedometer Based Intervention After Total Hip Replacement-A Pilot Study
Stability of Revision Total Hip Arthroplasty Implants Using Radiostereometric Analysis
Management of Postoperative Pain After Total Hip Arthroplasty
Bone Mineral Changes Around Stemless and Stemmed Cementless Femoral Components